Pharmaceuticals - Indian - Formulations
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 25.29 | 22.96 | 21.19 | 25.06 | 31.58 |
Total Expenses | 21.90 | 21.60 | 20.93 | 24.57 | 31.37 |
Profit Before Tax | 3.39 | 1.36 | 0.26 | 0.49 | 0.21 |
Profit After Tax | 2.40 | 0.97 | 0.09 | 0.30 | 0.10 |
Operating Profit after Depreciation | 4.04 | 1.97 | 0.73 | 0.97 | 0.58 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 10.35 | 10.87 | 11.29 | 11.35 | 11.28 |
Total Non Current Assets | 11.27 | 11.72 | 11.64 | 11.62 | 11.51 |
Total Current Assets | 27.31 | 20.87 | 15.43 | 14.72 | 14.30 |
TOTAL ASSETS | 38.58 | 32.59 | 27.07 | 26.34 | 25.82 |
Total Shareholder's Fund | 15.18 | 8.98 | 7.56 | 7.47 | 7.11 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -3.69 | -0.58 | 0.04 | -1.16 | 1.58 |
Net Cash used in Investing Activities | -0.33 | -0.28 | -0.59 | -0.02 | -0.45 |
Net Cash used in Financing Activities | 4.01 | 0.94 | 0.18 | 1.27 | -0.55 |
No data available
No data available
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Medicamen Organics Ltd | ₹41.85 | ₹48.96 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
04 Jan 2025, 10:28 am
09 Nov 2024, 02:44 pm
27 Aug 2024, 04:29 pm
28 Jun 2024, 12:45 pm